Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 209 of 1,261
  1. US 11583542

    Compositions of bile acids and phenylbutyrate compounds

    Amylyx Pharmaceuticals, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  2. US 11583541

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  3. US 11583489

    Flushable wipe and method of forming the same

    First Quality Tissue, LLC · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  4. US 11584933

    RNA interference in ocular indications

    Phio Pharmaceuticals Corp. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  5. US 11584780

    Adeno-associated virus capsid proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  6. US 11584760

    Dithio ETP derivatives

    The Regents of the University of California · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  7. US 11584966

    Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  8. US 11584737

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  9. US 11584735

    Solid forms of a plasma kallikrein inhibitor and salts thereof

    KalVista Pharmaceuticals Limited · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  10. US 11584733

    Selective histone deacetylase inhibitors for the treatment of human disease

    Shuttle Pharmaceuticals, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  11. US 11584736

    Heterocyclic P2Y14 receptor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  12. US 11578371

    Biomarkers for predicting tumor response to and toxicity of immunotherapy

    MIRA DX, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  13. US 11578313

    CRISPR-Cas effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  14. US 11578126

    Chimeric antigen receptor (CAR) comprising a CD19-binding domain

    AUTOLUS LIMITED · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  15. US 11578135

    Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  16. US 11578309

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  17. US 11576984

    Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  18. US 11578081

    Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof

    Medshine Discovery Inc. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  19. US 11576951

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    XERIS PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  20. US 11578066

    Fluoroalkyl-oxadiazoles and uses thereof

    Tenaya Therapeutics, Inc. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  21. US 11576871

    Formulations of cysteamine and cystamine

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  22. US 11576580

    Apparatus, systems and methods for intraoperative imaging

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  23. US 11576744

    Thermosensitive bio-adhesive hydrogel for removal of ureteral and renal stones

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  24. US 11576924

    Compounds for the prevention and treatment of diseases and the use thereof

    Galectin Sciences, LLC · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.